Concurrent inhibition of ALK and SRC kinases disrupts the ALK lung tumor cell proteome

Overview of attention for article published in Drug Resistance Updates, March 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#10 of 411)
High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

news: 4 news outlets
blogs: 1 blog

twitter: 6 X users

Readers on

mendeley: 3 Mendeley

Summary News Blogs X

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 1,579 followers.

RT @SotilloLab: Exciting news! 🚀 Our latest paper is published! “Concurrent inhibition of ALK and SRC kinases disrupts the ALK lung tumor c…

11 Apr 2024

Reply Repost Favourite

Happy to see it online! Enriching journey of learning and collaboration!🧪 Grateful to @Alberto_DiazJ for letting me join & for all the great moments we had along the way!🙌🏼⚡️couldn’t have done it without the support from all past&current @SotilloLa

02 Apr 2024

Reply Repost Favourite

RT @SotilloLab: Exciting news! 🚀 Our latest paper is published! “Concurrent inhibition of ALK and SRC kinases disrupts the ALK lung tumor c…

27 Mar 2024

Reply Repost Favourite

RT @SotilloLab: Exciting news! 🚀 Our latest paper is published! “Concurrent inhibition of ALK and SRC kinases disrupts the ALK lung tumor c…

27 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.